 initi coverag neutral rate
price target
messag initi coverag neutral rate
pt believ guidanc put forth achiev overal health
market great stabl neutral rate reflect fact valuat
expect share significantli rebound low ytd
vs share current trade roughli ebitda
slight premium histor averag price target assum
share trade ebitda
bottom line market seem comfort fallout
merger equip distribut realign bottom share alreadi
ytd vs expect reflect increas investor confid
turnaround would highlight stake could higher manag team
sever missteps/guid revis view guidanc
put forth achiev overal health market great stabl
assum correct compani abl meet guidanc benchmark
laid call believ share continu grind higher
upsid potenti pt
invest posit highlight follow invest posit lot stake
manag team restructuring/turnaround plan revenu growth margin
earn recoveri mode benefit easi yoy comp de-stock
rearview invest salesforc provid tailwind
distribut partner better place
invest risk highlight follow invest risk guidanc better
expect trigger elev expect end market trend
like continu volatil continu pressur high-tech equip price could weigh
margin execut track record mix gener econom slowdown could
diminish dentist invest appetit
valuat price target introduc ep estim
respect share current trade roughli ebitda
slight premium histor averag price target assum
share trade ebitda believ slight premium compani
histor valuat warrant compani earn growth rate recoveri
mode given price target impli roughli upsid current
level believ neutral rate appropri
page analyst certif import disclosur
world largest manufactur profession dental product technolog histori innov
servic dental industri patient world-wide develop manufactur market comprehens solut
offer includ dental oral health product well consum medic devic strong portfolio world class
brand compani product provid innov high-qual effect solut advanc patient care deliv better safer
faster dentistri compani conduct busi foreign countri roughli one-third compani sale
us balanc come compani organ two segment consum technolog
dental consum product consist valu ad dental suppli small equip use dental offic treatment
patient also includ special treatment product use within dental offic laboratori set includ product use
prepar dental applianc dental laboratori dental technolog product consist basic high-tech dental equip
treatment center imag equip comput aid design machin cad/cam system equip dental practition
laboratori product categori also includ high-tech state-of-the-art dental implant relat scan equip
treatment softwar orthodont applianc dental practition specialist dental laboratori
lot stake manag team restructuring/turnaround plan sinc merger dentspli sirona
difficult road investor invest stori sinc time mar integr oper issu
manag turnov earn disappoint januari casey brought ceo work alongsid
alexo cfo join compani month earlier unfortun volatil new manag team would
like trigger multipl guidanc revis throughout year label transit year would suggest
manag team manag team close month helm make signific chang
fulli own guidanc manag team comment coupl time critic compani issu
achiev guidanc attempt regain investor confid stock react favor initi guidanc
believ room share move higher compani execut goal year
revenu growth margin earn recoveri mode benefit easi yoy comp de-stock rearview
mention disappoint year compani result lower expect across board posit note
compani finish year better expect result provid initi guidanc better expect
respect guidanc compani project revenu growth consider better modestli neg intern
growth margin front compani expect gross oper margin expand year
respect recoveri revenu margin come confluenc factor includ inventori destock issu behind
compani stabil market on-going restructur cost reduct effort share alreadi react
posit guidanc continu believ level investor skeptic compani abil achiev result
invest salesforc provid tailwind effort reacceler revenu growth manag
emphas compani commit invest sale distribut infrastructur highlight program includ stronger
market commun program hire addit sale repres back addit compani
implement sale forc effect program highlight signific upsid potenti exist across entir
busi beyond compani process assess augment skill capabl perform
salespeopl global roll new well tool includ clinic product train part broader
program design improv xray go-to-market capabl lastli compani also provid interest incent within
compens structur exampl salespeopl receiv incent comp lead gener new primescan
product believ program could potenti provid underappreci tailwind
distribut partner better place two difficult year compani exacerb
transit equip distribut realign agreement open network arrang addit consum market
volatil still difficult fulli understand rel histor standard lastli make matter wors two primari
distributor company-specif issu also made investor concern sector broadli much seem
rearview mirror equip distribut network seem better place inventori destock issu seem
behind compani consum busi seem stabil least time expect stronger growth
balanc year easier comparison recent product launch symbiot distribut relationship
chang go-to-market strategi benefit compani product line consum equip side
busi
page analyst certif import disclosur
guidanc better expect trigger elev expect earn report compani
report better expect quarter augment releas guidanc also better expect remind
compani project revenu growth consider better modestli neg growth margin
front compani expect gross oper margin expand year respect high short
interest head print share react posit trade almost level ytd vs
 share continu grind higher sinc march report investor digest on-going transit effort
compani achiev guidanc given recent develop short interest come consider
valuat share price-to-earnings ebitda basi respect would character valuat
slight premium histor standard clear expect higher today versu short month ago
end market trend like continu volatil economi strong unemploy near
low surpris industri growth metric volatil past coupl year comment
support across industri manufactur distributor report similar volatil make littl frustrat
compani abl definit explain volatil somewhat inconsist multi-decad trend
increment concern xray guidanc call normal revenu growth past coupl year
anyth normal would also highlight sever guidanc misstep last year investor limit patienc
anoth fals start far transit concern abil execut guidanc signific impact
manag credibl view
continu pressur high-tech equip price could weigh margin beyond transitori equip distribut issu
describ compani comment number time observ increas competit well chang
channel distribut compani competitor digit x-ray imag market area sirona use domin
much higher price-point spend time dental industri tradeshow reinforc competit high-tech equip market
becom past sever year sever signific dental manufactur continu innov aggress investor
continu close monitor competit landscap
also horizon growth dso opinion prove littl bit double-edg sword bigger
organ acceler adopt technolog demand better price confer call manag
ask risk addit price pressur comment compani made signific price adjust core
market princip us price adjust adequ reflect guidanc manag also comment
compani believ product price perspect competit respect market
execut track record mix three year sinc merger roughli month sinc current
manag team took helm investor appear grown fatigu transit stori compani believ
reluct buy sustain turnaround share concern degre expect path forward incorpor
volatil investor may anticip said dental industri still good industri natur growth owe
favor demograph evolv technolog innov global leader consum solid competit posit
equip market continu believ enviabl posit execut compani oper initi
gener econom slowdown could diminish dentist invest appetit almost year current econom
expans cycl much concern recess economist appreci thing hard predict
fair obviou say deceler global growth would dampen effect xray core busi
secondli would note stock histor quit sensit inflect organ growth rate far share
concern take comfort compani wide telegraph modest industri growth confer sever
differ confer call believ thought slow global growth seem somewhat embed expect also
posit note data point slow econom growth wide public complet surpris stark
chang industri growth rate
valu primarili util ev/ebitda valuat metric although also consid price-to-earn assess multipl
rel histor averag industri peer context current oper futur outlook compani industri
backdrop believ ev/ebitda common metric evalu valuat share current trade roughli
ebitda slight premium histor averag valuat expect share
significantli rebound low share alreadi year-to-d vs price target base
ebitda believ slight premium compani histor valuat warrant compani earn
growth rate recoveri mode said believ compani alreadi receiv fair amount credit
turnaround given price target impli roughli upsid current level believ neutral rate appropri
mention previous rate share neutral larg owe fact compani alreadi receiv fair amount
credit turnaround low key risk upsid near-term organ growth compani dental
technolog equip busi reacceler earlier faster expect key downsid risk near-term would
dental consum busi slow greater expect
page analyst certif import disclosur
issu research report guggenheim secur llc guggenheim secur research analyst whose name appear report
herebi certifi view express report accur reflect research analyst person view subject
secur issuer discuss herein ii part research analyst compens directli indirectli relat specif
recommend view express research analyst
research analyst research associ receiv compens base upon variou factor includ qualiti research investor client
feedback guggenheim secur llc overal revenu includ invest bank revenu
guggenheim secur llc affili expect receiv intend seek compens invest bank servic dentspli
sirona inc next month
pleas refer websit company-specif disclosur referenc report http //guggenheimsecur bluematrix com/sellside/
disclosur action disclosur inform also avail complianc madison avenu new york ny
